A single COA reused across multiple batches means they are not testing each production run independently
For high-performers, that distinction matters
What varies is the incidence, the severity curve, and (in retatrutide's case) the appearance of a new signal
This class effect flows directly from the shared GLP-1 mechanism (delayed gastric emptying and central appetite suppression)
What Clinical Trials Show (Phase 2 Trial Data) In the MariTide phase 2 trial, which compared multiple dosage strengths to placebo: Some groups achieved significant average weight loss, approaching levels seen with existing GLP-1 medications
Peptide YY Physiology and Related Medicines Peptide YY (PYY) is co-secreted with GLP-1 by endocrine cells in the intestine and converted to its active form PYY 3-36, which acts via Y2 receptors to inhibit neuropeptide Y (NPY) neurons and promote satiety 1,22